The genome sequence of Acinetobacter baumannii isolated from a septicemic patient in a local hospital in Malaysia
Acinetobacter baumannii is a Gram negative, strictly aerobic clinical pathogen causing mostly nosocomial infections globally. The DNA of an isolate from the blood of a local septicemic patient was sequenced using the Illumina GA IIx. The draft genome generated is 4,178,008. bp with a G. +. C content...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier Inc.
2015
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher View in Scopus |
| LEADER | 02069nam a2200493Ia 4500 | ||
|---|---|---|---|
| 001 | 10.1016-j.gdata.2015.08.028 | ||
| 008 | 220112s2015 CNT 000 0 und d | ||
| 020 | |a 22135960 (ISSN) | ||
| 245 | 1 | 0 | |a The genome sequence of Acinetobacter baumannii isolated from a septicemic patient in a local hospital in Malaysia |
| 260 | 0 | |b Elsevier Inc. |c 2015 | |
| 856 | |z View Fulltext in Publisher |u https://doi.org/10.1016/j.gdata.2015.08.028 | ||
| 856 | |z View in Scopus |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84941056907&doi=10.1016%2fj.gdata.2015.08.028&partnerID=40&md5=0f9f6c974ac50f9080717bc8802b3400 | ||
| 520 | 3 | |a Acinetobacter baumannii is a Gram negative, strictly aerobic clinical pathogen causing mostly nosocomial infections globally. The DNA of an isolate from the blood of a local septicemic patient was sequenced using the Illumina GA IIx. The draft genome generated is 4,178,008. bp with a G. +. C content of 42%. From the annotation results, 47 resistance determinants including 16 multidrug resistance (MDR) genes were identified. The data may be accessed via the GenBank WGS master accession number APWV00000000. © 2015. | |
| 650 | 0 | 4 | |a Acinetobacter baumannii |
| 650 | 0 | 4 | |a acriflavine |
| 650 | 0 | 4 | |a albicidin |
| 650 | 0 | 4 | |a antiinfective agent |
| 650 | 0 | 4 | |a Article |
| 650 | 0 | 4 | |a bacterial DNA |
| 650 | 0 | 4 | |a bacterial gene |
| 650 | 0 | 4 | |a blood sampling |
| 650 | 0 | 4 | |a carbapenemase |
| 650 | 0 | 4 | |a case report |
| 650 | 0 | 4 | |a DNA base composition |
| 650 | 0 | 4 | |a fosmidomycin |
| 650 | 0 | 4 | |a gene insertion sequence |
| 650 | 0 | 4 | |a gene sequence |
| 650 | 0 | 4 | |a Genome |
| 650 | 0 | 4 | |a hospital patient |
| 650 | 0 | 4 | |a human |
| 650 | 0 | 4 | |a Malaysia |
| 650 | 0 | 4 | |a male |
| 650 | 0 | 4 | |a multidrug resistance |
| 650 | 0 | 4 | |a operon |
| 650 | 0 | 4 | |a organoarsenic derivative |
| 650 | 0 | 4 | |a priority journal |
| 650 | 0 | 4 | |a septicemia |
| 650 | 0 | 4 | |a tetronasin |
| 650 | 0 | 4 | |a transposon |
| 650 | 0 | 4 | |a unclassified drug |
| 700 | 1 | 0 | |a Izwan, I. |e author |
| 700 | 1 | 0 | |a Salleh, M.Z. |e author |
| 700 | 1 | 0 | |a Teh, L.K. |e author |
| 773 | |t Genomics Data | ||